Essex Woodlands Management as of Sept. 30, 2018
Portfolio Holdings for Essex Woodlands Management
Essex Woodlands Management holds 8 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| pSivida | 31.1 | $150M | 42M | 3.57 | |
| Axogen (AXGN) | 28.4 | $137M | 3.7M | 36.85 | |
| Corium Intl | 18.5 | $89M | 9.4M | 9.51 | |
| Revance Therapeutics (RVNC) | 17.3 | $83M | 3.3M | 24.85 | |
| MediciNova (MNOV) | 3.0 | $15M | 1.2M | 12.49 | |
| Endologix | 1.4 | $6.7M | 1.3M | 5.32 | |
| Catalyst Biosciences | 0.2 | $861k | 79k | 10.95 | |
| Acura Pharmaceuticals (ACUR) | 0.1 | $372k | 2.0M | 0.19 |
